Comparative Pharmacology
Head-to-head clinical analysis: PHISO SCRUB versus PHISOHEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PHISO SCRUB versus PHISOHEX.
PHISO-SCRUB vs PHISOHEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Phiso-Scrub is a topical antiseptic containing triclosan, which inhibits bacterial fatty acid synthesis by targeting enoyl-acyl carrier protein reductase (FabI), leading to disruption of cell membrane integrity and bacterial cell death.
Disrupts bacterial cell wall synthesis by binding to the bacterial ribosome and inhibiting protein synthesis; also has surfactant properties that disrupt bacterial cell membrane integrity.
Topical application to affected area once daily; chlorhexidine gluconate 4% scrub, lather for 3-5 minutes, rinse thoroughly.
Apply topically as a 3% emulsion to affected area, rinse thoroughly; typically used 1-2 times daily for up to 10 days.
None Documented
None Documented
Approximately 8-12 hours in patients with normal renal function (CrCl >90 mL/min). Half-life is significantly prolonged in renal impairment (up to 40 hours in ESRD).
Terminal elimination half-life approximately 6-7 hours in adults with normal renal function. Prolonged in renal impairment (up to 20 hours) due to reduced clearance of active metabolite (pentachlorophenol).
Primarily renal excretion of unchanged drug (approximately 70-80% of absorbed dose). Biliary/fecal elimination accounts for the remainder (20-30%).
Renal (biliary/fecal negligible). Up to 10% of dose excreted unchanged in urine; remainder as metabolites (glucuronide and sulfate conjugates).
Category C
Category C
Antiseptic
Antiseptic